Cascade Investment Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Cascade Investment Advisors's DGX Position: Q2 2022 in Review
Cascade Investment Advisors sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 9,445 shares — an estimated $1.29M sold.
Cascade Investment Advisors first reported a position in DGX in Q2 2016 and held it in 23 quarters. The position peaked at $1.65M in Q4 2021. 852 funds tracked by Wall St. Rank hold DGX as of Q2 2022.
- Cascade Investment Advisors reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
- Cascade Investment Advisors sold 9,445 Quest Diagnostics shares in Q2 2022, an estimated $1.29M.
- Cascade Investment Advisors first reported a position in Quest Diagnostics in Q2 2016 and held it in 23 quarters.
- Cascade Investment Advisors's Quest Diagnostics position peaked at $1.65M in Q4 2021.
- 852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.
Based on Cascade Investment Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.